Red X iconGreen tick iconYellow tick icon

Contact Details

Phone
+64 3 364 0544
Email
gabi.dachs@otago.ac.nz
Position
Research Professor
Department
Department of Pathology and Molecular Medicine (Christchurch)
Qualifications
BSc PhD
Research summary
Cancer research

Research

Professor Gabi Dachs completed her undergraduate and PhD studies in Cape Town, South Africa, followed by postdoctoral work at the MRC Harwell in the United Kingdom.

Prior to joining the University of Otago in Christchurch, Professor Dachs worked as senior scientist at the Gray Cancer Institute in London, UK.

Professor Gabi Dachs is interested in why human tumours are difficult to treat, and in new ways of treating them. Current research interests at present include:

  • Can we dampen the activity of the global transcription factor HIF-1 using vitamin C? Can we reduce tumour growth in mice using vitamin C? Can we increase vitamin C in cancer cells using gene therapy?
  • Why do obese cancer patients often fare worse than non-obese patients? Can we identify the molecular factors associated with obesity in cancer? What effect do these obesity-related factors have on chemotherapy?
  • Which human enzymes are responsible for the activation of novel anticancer prodrugs (in collaboration with Auckland Cancer Society Research Centre)? Can this knowledge guide clinical use of these agents?
  • Can we improve gene directed enzyme prodrug therapy combinations to target solid tumours or their vasculature?

Publications

Tino, A. B., Sykes, P. H., Dachs, G. U., & Chitcholtan, K. (2026). Targeting phosphoinositide 3-kinase to reduce the progression of ovarian cancer cells in a 3D collagen model. Biomolecules, 16, 377. doi: 10.3390/biom16030377 Journal - Research Article

Tino, A. B., Dachs, G. U., Sykes, P. H., & Chitcholtan, K. (2025). Impact of tumor necrosis factor-alpha and lysophosphatidic acid on the behavior of ovarian cancer cells in a three-dimensional collagen hydrogel. Journal of Obstetrics & Gynaecology Research, 51, e70026. doi: 10.1111/jog.70026 Journal - Research Article

Brook, E. M., Helem, S. J., McDonald, C. C. M., Magon, N. J., Selwood, A. I., Harwood, D. T., … Hampton, M. B., & Dachs, G. U. (2025). Portimine A maintains bioactivity following exposure to liver microsomes and cell lysates: No evidence for significant metabolic inactivation. Medical Oncology, 42, 278. doi: 10.1007/s12032-025-02826-x Journal - Research Article

Praditi, C., Beverley-Stone, E., Reid, M., Burgess, E. R., Crake, R. L., Vissers, M. C. M., Royds, J. A., Slatter, T. L., Dachs, G. U., & Phillips, E. (2025). Iron content of glioblastoma tumours and role of ferrous iron in the hypoxic response in vitro. Frontiers in Oncology, 15, 1536549. doi: 10.3389/fonc.2025.1536549 Journal - Research Article

Burgess, E. R., Praditi, C., Phillips, E., Vissers, M. C. M., Robinson, B. A., Dachs, G. U., & Wiggins, G. A. R. (2025). Role of sodium-dependent vitamin C transporter-2 and ascorbate in regulating the hypoxic pathway in cultured glioblastoma cells. Journal of Cellular Biochemistry, 126, e30658. doi: 10.1002/jcb.30658 Journal - Research Article

Back to top